Adjunctive Greater Occipital Nerve Block for Pain Control in Medically Refractory Acute Primary Angle Closure: An Observational Study

辅助性枕大神经阻滞治疗药物难治性急性原发性闭角型青光眼疼痛:一项观察性研究

阅读:1

Abstract

Background: Acute primary angle closure (APAC) is an ophthalmic emergency characterized by abrupt elevation of intraocular pressure (IOP) and severe ocular pain and headache. While acute management prioritizes IOP reduction, supportive analgesic strategies during the preoperative waiting period in medically refractory cases remain insufficiently studied. We evaluated short-term changes in the pain intensity and safety of adjunctive greater occipital nerve block (GONB) in medically refractory APAC. Methods: This retrospective observational study included 34 patients with medically refractory APAC who received GONB during the preoperative waiting period. Headache intensity was measured using an 11-point Numeric Rating Scale (NRS) at baseline, 30 min, and 60 min. Longitudinal changes were analyzed using a linear mixed-effects model. Responder analyses were reported with 95% confidence intervals (Wilson method). No multivariable modeling or NNT estimation was performed in the revised analysis. Results: Baseline NRS was 7.8 ± 1.1, decreasing to 4.1 ± 1.5 at 30 min and 3.6 ± 1.3 at 60 min (both p < 0.001). The mean baseline-to-60 min change was -4.21 (95% CI, -4.88 to -3.54). Clinically meaningful pain relief (≥3-point reduction) at 60 min occurred in 79.4% (95% CI, 63.2-89.7%). In linear mixed-effects modeling, time remained a significant fixed effect (p < 0.001). Conclusions: Adjunctive GONB was associated with a rapid reduction in pain intensity in medically refractory APAC. These findings should be interpreted cautiously, given the uncontrolled design and concurrent treatment. Prospective controlled studies are warranted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。